This paper proposes a new methodology to assess demand and price-elasticity for health care, based on patients' stated willingness to pay (WTP) values for certain aspects of health care quality improvements. A conceptual analysis of how respondents consider contingent valuation (CV) questions...

Objective: To evaluate the potential cost savings of using sequential high dose chemotherapy (HDC), with granulocyte colony-stimulating factor (filgrastim) and stem cell support, rather than single course administration of HDC with bone marrow transplantation (BMT) or peripheral blood stem cell...

The usual implementation of contingent valuation (CV), in the context of priorities setting for allocation of public funds in health care, is to develop as many surveys as there are programmes, i.e. to perform separate evaluations (SE). In the EuroWill project, three health programmes (for heart...

[fre] Boubou Cissé Stéphane Luchini Jean-Paul Moatti Recouvrement des coûts et demande de soins dans les PED Suite à la crise financière qui a durement frappé les pays en développe- ment dès le début des années 1980, l'instauration du recouvrement des coûts d'accès aux soins...

This paper argues that the sociology of deviance can be used to improve our understanding of some difficulties and unintended effects of health-promotion interventions designed to change risk behaviours, especially drug-taking. Firstly, many people engaged in 'risk behaviours' tend to deny the...

This paper analyzes the redistributive effect and progressivity associated with the current health care financing schemes in the Occupied Palestinian Territory, using data from the first Palestinian Household Health Expenditure Survey conducted in 2004. The paper goes beyond the commonly used...

Since 2000, the fight against aids, tuberculosis and malaria has contributed to significant shifts in the main paradigms of the health economics literature applied to developing countries: improvements in public health of the population are now considered a prerequisite, rather than a...

Criteria for initiation of highly active antiretroviral treatments (haart) in hiv-infected patients remain a matter of debate world-wide because short-term benefits have to be balanced with costs of these therapies, and restrictions placed on future treatment options if resistant viral strains...